Japan investigates cancer "articles"

Share this article:

Japan's Health, Labor and Welfare Ministry is investigating a series of advertorials that were dressed up as articles but were in fact cancer-drug marketing efforts. Pharmalot reports that five unnamed drugmakers paid $18,500-$56,300 for articles in an unnamed publication so their cancer drugs would be slipped into articles. The setup is similar to television and movie product placement: the magazine wrote the article, entered quotes and plugged in drug names depending on payment.

Pharmalot says the publisher says everything done was legally.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Avastin pockets another Priority Review label

It's the second for this cancer drug in two weeks.

Court invalidates some healthcare subsidies

The lawsuit has been wending its way through the courts for a while, and, although it is being deliberated in several other venues, the decision is part of a legal dispute that puts patients in the 36 states offering federal exchanges in limbo.

FDA generic division overhaul kicks in

The Food and Drug Administration has been intent on elevating and reorganizing its office of Generic Drugs since 2012.